CUTE (Chronic Urticaria Treatment Evaluation)

PHASE4CompletedINTERVENTIONAL
Enrollment

886

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Chronic Idiopathic Urticaria
Interventions
DRUG

Levocetirizine

5mg oral capsules, once daily, 4 week duration

DRUG

Desloratadine

5mg oral capsules, once daily, 4 week duration

Trial Locations (80)

Unknown

Bruges

Brussels

Liège

Merksem

Sint-Niklaas

Woluwe-St-Lamb

Bernay

Besançon

Hyères

Les Milles

Marseille

Montpellier

Nancy

Nantes

Nice

Nîmes

Paris

Poitiers

Quimper

Saint-Mandé

Troyes

Valence

Villejuif

Augsburg

Berlin

Cologne

Dresden

Düsseldorf

Erlangen

Göttingen

Hamburg

Hanover

Leipzig

Mahlow

Mainz

München

Viersen

Caserta

Catania

Cesena

Genova

Modena

Palermo

Pavia

Roma

Siena

Udine

Verona

Johor Bharu

Kelantan

Kuala Lumpur

Negeri Sembilan

Perak

Pulau Pinang

Sarawak

Brasov

Bucharest

Dolj

Sibiu

Cape Town

Durban

Lenasia

A Coruña

Albacete

Barcelona

Granada

Madrid

Málaga

Murcia (El Palmar)

Oviedo

Santiago de Compostela

Seville

Valencia

Amersham

Cardiff

Irvine

Leicester

London

Nuneaton

Salford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY